Low radiographic muscle density is associated with lower overall and disease-free survival in early-stage colorectal cancer patients

[1] Anderson DE(2013)Variations of CT-based trunk muscle attenuation by age, sex, and specific muscle The J Gerontol Ser A Biol Sci Med Sci 68 317-323

[2] D’Agostino JM(2013)Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies Cancer 119 3377-3384

[3] Bruno AG(2016)Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer J Clin Oncol 34 1339-1344

[4] Demissie S(2016)Reply to L.E. Daly et al J Clin Oncol 34 3817-1015

[5] Kiel DP(2017)Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study) Cancer Epidemiol Prev Biomarkers 26 1008-3817

[6] Bouxsein ML(2016)Response to “Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer” J Clin Oncol 34 3816-326

[7] Antoun S(2017)Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer J Cachexia Sarcopenia Muscle 8 317-155

[8] Lanoy E(2017)Subcutaneous adiposity is an independent predictor of mortality in cancer patients Br J Cancer 117 148-140

[9] Iacovelli R(2015)Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma J Hepatol 63 131-110

[10] Albiges-Sauvin L(2000)Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content J Appl Physiol 89 104-2165

[1] Anderson DE(2013)Variations of CT-based trunk muscle attenuation by age, sex, and specific muscle The J Gerontol Ser A Biol Sci Med Sci 68 317-323

[2] D’Agostino JM(2013)Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies Cancer 119 3377-3384

[3] Bruno AG(2016)Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer J Clin Oncol 34 1339-1344

[4] Demissie S(2016)Reply to L.E. Daly et al J Clin Oncol 34 3817-1015

[5] Kiel DP(2017)Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study) Cancer Epidemiol Prev Biomarkers 26 1008-3817

[6] Bouxsein ML(2016)Response to “Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer” J Clin Oncol 34 3816-326

[7] Antoun S(2017)Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer J Cachexia Sarcopenia Muscle 8 317-155

[8] Lanoy E(2017)Subcutaneous adiposity is an independent predictor of mortality in cancer patients Br J Cancer 117 148-140

[9] Iacovelli R(2015)Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma J Hepatol 63 131-110

[10] Albiges-Sauvin L(2000)Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content J Appl Physiol 89 104-2165